Key Takeaways for Dental Practice Owners
- Dental practice succession planning works best as a structured, multi-phase process that starts years before buyer conversations and protects both financial results and practice legacy.
- Premier practices with $1 million or more in revenue often face an information gap versus corporate buyers, and a defensible valuation plus a competitive process can help prevent leaving millions on the table.
- Owners benefit from comparing doctor-to-doctor and DSO pathways side by side, modeling after-tax proceeds, cash at close, and post-close commitments over several time horizons.
- Deal structure, purchase price allocation, rollover equity, and earnouts can shift net proceeds by hundreds of thousands of dollars, so professional tax and legal guidance can be critical.
- McLerran & Associates has guided roughly 2,000 successful transactions; connect with the team for a confidential conversation to start your succession plan.
Phase 1: Determine Your Exit Timeline
Every succession plan starts with a clear view of when and why an owner wants to exit. The average U.S. dentist retirement age reached 68.7 years in 2024, up from 64.7 years in 2001, so the planning window for most owners aged 55 and older often spans 10 to 15 years. Starting that process early creates options, while starting late compresses them.
The 5 D’s of succession planning offer a practical framework for anchoring the timeline: Death, Disability, Divorce, Distress, and Disagreement (partnership dissolution). Many dental practice transitions occur under urgent conditions such as health events, financial distress, or partnership breakdowns, which compress negotiating room and planning timelines. Owners who wait for one of the 5 D’s to force the issue often see materially weaker outcomes than those who plan proactively.
Timeline clarity also shapes which transition pathway can make sense. An owner 8 to 10 years from exit may benefit from a partnership or vest-out structure. An owner 2 to 3 years out may be better positioned for a full sale to another dentist or to a corporate buyer. An owner already fielding unsolicited offers usually needs a structured process immediately, before a single-buyer negotiation anchors the price.
Phase 2: Conduct a Practice Valuation
A defensible valuation forms the foundation of every successful transition. Without one, the buyer, not the seller, controls the story about what the practice is worth.
Two primary valuation approaches usually apply, depending on the buyer type. In doctor-to-doctor transactions, value is typically expressed as 65–85% of annual collections or as a multiple of Seller’s Discretionary Earnings (SDE, which is net income plus the owner’s full compensation and personal add-backs). In DSO and private equity transactions, value is anchored to normalized EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), where the owner’s compensation is replaced with a market-rate associate salary before the multiple is applied. Institutional bidders often produce different normalized EBITDA calculations on identical financial data because they use different normalization methods. That variance makes the quality of the seller’s own analysis especially important and shows why shortcuts in the valuation process can create risk.
A “free” or back-of-the-napkin valuation, often offered as a lead magnet by some brokers, rarely survives buyer due diligence. Weak add-back documentation, unsupported revenue claims, or an incorrect normalization method can cause a deal to be re-traded (renegotiated downward) after the letter of intent is signed, or to collapse entirely. A formal dental practice appraisal produces a certified fair market value, yet in institutional transactions the buyer’s Quality of Earnings analysis, which is a detailed forensic review of the seller’s financials, usually overrides any seller-side appraisal that cannot withstand scrutiny.
McLerran & Associates builds CPA-led, diligence-grade EBITDA analyses from the ground up, unpacking every add-back, cross-referencing practice management software data against tax returns, and producing a number that tends to hold when buyers review it closely. For owners weighing both pathways, the firm delivers a side-by-side valuation that quantifies the practice’s worth in both the private-buyer and DSO markets.
Download the free McLerran & Associates succession planning checklist, a practical 7-step PDF that walks you through every phase of the process. Get your checklist and start planning your transition today.
Phase 3: Evaluate Transition Models Side by Side
Once a defensible valuation is in place, the next step is comparing the two primary transition pathways side by side. McLerran & Associates works both paths in roughly equal measure, an approximately 50/50 split across its roughly 2,000 completed transactions, which allows a genuine comparison that single-lane brokers usually cannot provide.
The table below compares the two pathways on identical metrics and highlights the trade-offs between immediate liquidity and longer-term commitment that define each path. All figures are directional ranges drawn from current market data and should be confirmed through a formal valuation for any specific practice.
| Metric | Doctor-to-Doctor | DSO / Private Equity |
|---|---|---|
| Valuation method | 65–85% of annual collections or multiple of SDE | Normalized EBITDA multiple; ranges vary by practice size and profile |
| Cash at close | Typically 100% | Typically 60–75%, with earnouts and rollover equity comprising the remainder |
| Post-close work commitment | Typically 4–8 weeks (walk-away) or structured vest-out | Typically a minimum of five years as a clinical associate |
| Transaction timeline | Typically 60–120 days (2–4 months) | 3–6 months of active process due to corporate diligence |
Two rules of thumb can help owners in the middle of the market orient themselves before a formal valuation.
The 50-40-30 rule is a rough benchmark sometimes used to assess DSO eligibility. Practices generating $50,000 or more per operatory per month, with 40% or more of revenue from hygiene, and overhead at or below 30% above the doctor’s compensation often attract strong institutional interest. These are directional indicators rather than guarantees, and a formal EBITDA analysis will always carry more weight.
The 3-3-3 rule is a planning guide. Allow 3 years to prepare the practice for sale, 3 years of post-close transition involvement in a DSO context, and 3 years of financial runway post-exit. Owners who internalize this timeline usually approach the process with the lead time needed to build value rather than reacting to circumstances.
For owners in the $1.5 million to $3 million revenue range, who are genuinely able to go either direction, McLerran’s multi-year, multi-structure financial forecasting models what each path can net after tax over 3-, 5-, 7-, and 10-year horizons, including conservative recapitalization assumptions for the equity component of DSO deals. That modeling offers a practical way to compare a 100% cash doctor-to-doctor exit against a DSO deal that may be 60–75% cash, with the remainder in rollover equity and earnout.
Phase 4: Understand Tax Implications and Deal Structure
Deal structure and tax treatment can move the net proceeds of a dental practice sale by hundreds of thousands of dollars or more, depending on how the purchase price is allocated among goodwill, equipment, consulting agreements, and non-competes.
The key structural concepts owners can benefit from understanding, and then discussing with their own CPA and tax attorney, include the following. Each concept acts as a lever that can shift net proceeds, and together they influence whether a deal’s headline price translates into lasting wealth.
Purchase price allocation. In most dental practice sales, 95% or more are structured as asset sales. Within an asset sale, proceeds allocated to goodwill and patient records are generally taxed at long-term capital gains rates, currently 20% federal plus a 3.8% Net Investment Income Tax for higher earners. Proceeds allocated to equipment (depreciation recapture) and restrictive covenants are taxed as ordinary income at rates up to 37%. Maximizing the goodwill allocation is usually in the seller’s interest.
Rollover equity structures. DSO deals routinely include rollover equity, which converts a portion of the proceeds into an ownership stake in the acquiring platform rather than paying that amount as cash. As much as 40% of a DSO deal can be paid in equity. That equity can be held at the joint-venture (JV) level, tied to the individual practice with distributions, or at the holding-company level, which offers no distributions but potentially higher upside if the platform recapitalizes at a higher multiple. Rollover equity remains illiquid until a future recapitalization or sale event, typically 3 to 7 years later, and carries platform performance risk.
Earnouts. An earnout is a contingent payment tied to post-close financial performance, typically EBITDA or collections targets over 12 to 36 months. Earnout structures are a leading source of post-sale disputes when overhead allocations, revenue definitions, or termination rights are not clearly negotiated in the letter of intent. Negotiating non-punitive earnout terms, such as pro-rata provisions that pay a proportional amount for near-misses on targets, can be a meaningful part of protecting the seller’s total economic outcome.
This section is educational only. Every owner should work with a qualified CPA and dental transaction attorney before making any decisions about deal structure or tax strategy.
Phase 5: Build Emergency Contingency Plans
Succession planning covers both the planned exit and what happens if an owner cannot continue practicing due to death, disability, or another unexpected event, which relate to the first two of the 5 D’s.
The most common mistake in succession planning is treating it as a single event rather than an ongoing process. Owners who build a succession plan once and file it away, without updating it as the practice grows, as tax laws change, or as the buyer market shifts, are effectively planning for a practice that no longer exists. A plan built in 2019 does not reflect today’s DSO landscape, current EBITDA multiples, or the current tax environment.
Practical contingency elements include a current, defensible practice valuation, a buy-sell agreement if the practice has partners, disability and life insurance sized to the practice’s current value, and a designated successor or transition advisor who can execute a sale under time pressure if needed. McLerran & Associates will update a valuation for free one year after the initial engagement if the owner is not yet ready to sell. Many dental entrepreneurs want a formal succession plan but few have one, which leaves a large share of practice owners exposed to the 5 D’s without a plan in place.
7-Step Succession Planning Checklist for Dental Practices
The following checklist can be used independently, without engaging any advisor. It is designed to help owners assess their readiness and identify gaps before beginning a formal process.
- Define your exit timeline and “why.” Identify your target exit year and the primary driver, such as retirement, partnership, growth capital, or legacy protection. This decision shapes every subsequent step.
- Obtain a diligence-grade practice valuation. Commission a CPA-led EBITDA analysis that documents every add-back and can withstand buyer scrutiny. Avoid back-of-the-napkin or free valuations that are unlikely to hold up in due diligence.
- Model both transition pathways. Request a side-by-side financial forecast comparing doctor-to-doctor and DSO outcomes over multiple time horizons, including after-tax proceeds under different deal structures.
- Prepare your financial documentation. Organize 3 to 5 years of tax returns, profit and loss statements, production reports by provider, accounts receivable aging, and practice management software data.
- Address value-killers before going to market. Reduce owner dependency by developing associate coverage, secure a lease with at least 5 to 10 years remaining, update equipment, and stabilize staff. Dental practices that prepare thoroughly can sell for more and often achieve significantly higher close rates than unprepared practices.
- Assemble your advisor team. Engage a dental-specific sell-side advisor, a CPA with dental transaction experience, a dental M&A attorney, and a financial planner aligned with your post-sale goals, ideally 2 to 3 years before your target exit date.
- Build and maintain a contingency plan. Ensure a current valuation, buy-sell agreement if applicable, and disability and life insurance are in place and updated annually.
Common Pitfalls and How a Structured Process Helps
Three pitfalls account for much of the value loss in dental practice transitions.
Single-buyer negotiations. An owner who approaches one DSO directly or accepts an unsolicited offer has no competitive tension and no way to know whether that offer reflects the real market. DSO opening offers are often below best-and-final offers on practices that proceed to a multi-bid process. A structured, auction-style process among a vetted pool of buyers, such as the 45 to 60 day processes McLerran & Associates typically runs that often generate around 10 offers, creates the competitive tension that can push price and terms in the seller’s favor.
Weak valuations. A valuation that cannot survive a buyer’s Quality of Earnings review becomes the anchor for a re-trade, a post-LOI price reduction that the seller has limited leverage to resist once exclusivity has been granted. Institutional buyers apply normalization adjustments that can compress seller-reported EBITDA by 30–50% when undocumented addback items receive a standard QoE haircut if the seller’s own analysis has not already addressed them. Strong, diligence-level work done up front reduces that vulnerability.
Lack of buyer vetting. Not every DSO is a good partner. Rising interest rates, higher operating costs, and the complexity of managing large multi-location platforms have placed new pressure on heavily leveraged DSOs, and some organizations have experienced lender control transitions. An owner who rolls equity into an undercapitalized platform may find that equity worth far less than projected or nothing at all. McLerran & Associates vets buyers like investments and has blacklisted DSOs known for poor post-close environments, so poorly run buyers do not reach the table.
The combined effect of these three pitfalls, single-buyer exposure, weak valuation, and unvetted buyers, helps explain why do-it-yourself close rates can run as low as 15–20%, compared to roughly 85–90% for McLerran & Associates’ clients. The difference usually reflects process rather than luck.
Conclusion: Select the Transition Path That Fits Your Goals
Dental practice succession planning works best as a multi-phase process that starts years before a sale and concludes when the deal closes on terms that protect both the owner’s financial outcome and the legacy they have built. Owners who run a structured, competitive process with strong valuations and a vetted buyer pool often see materially better outcomes than those who sell alone, accept the first offer, or work with advisors who focus on only one side of the market.
McLerran & Associates has guided practice owners through the roughly 2,000 transactions mentioned earlier, totaling approximately $2 billion in closed volume, with more than 10,000 practices evaluated over roughly 35 years. The firm works both the doctor-to-doctor and DSO pathways in approximately equal measure, one of the few firms in the country that can deliver a genuine side-by-side comparison, and typically transacts at roughly 85–90%, versus an industry norm closer to 35–40%.
For owners who are not yet ready to sell but want to get educated before making one of the largest financial decisions of their careers, the McLerran M&A Summit on October 29–30, 2026 is designed for that purpose. Attendees receive 4 CE credits and a complimentary practice valuation, a $2,500 value, with no pressure to engage.
When you are ready to take the next step, whether that involves a valuation, a pathway comparison, or simply clarifying your options, connect with McLerran & Associates to explore your best path forward. Call (512) 900-7989 or email info@dentaltransitions.com to get started.
Frequently Asked Questions
What is the difference between EBITDA and SDE in a dental practice valuation?
Both EBITDA and SDE, or Seller’s Discretionary Earnings, measure a dental practice’s true profitability after removing expenses that would not apply to a new owner. The key difference lies in how they treat the owner’s compensation. SDE adds back the owner’s full salary and benefits and reflects the total financial benefit available to a single owner-operator who works in the practice. EBITDA replaces the owner’s compensation with a market-rate associate salary and reflects what the practice earns as a business that can function without the specific owner. DSOs and private equity buyers use normalized EBITDA because they are purchasing a business, not a job. Individual dentist buyers typically use SDE because they plan to work in the practice themselves. For practices above roughly $1 million in collections, or any transaction involving a corporate buyer, EBITDA is usually the appropriate method, and the quality of the normalization analysis, meaning the add-backs and adjustments, often determines whether the number holds up under buyer scrutiny.
How long does a dental practice succession planning process typically take?
The full succession planning process, from the first valuation through a closed transaction, commonly spans 6 to 18 months depending on the transition pathway. Doctor-to-doctor transactions typically close in 4 to 6 months from market launch. DSO and private equity transactions generally require 6 to 12 months, and sometimes longer for complex multi-location deals, because of institutional due diligence, quality of earnings reviews, equity rollover documentation, and internal approvals. The preparation that can maximize value, such as reducing owner dependency, cleaning up financials, securing favorable lease terms, and building a defensible EBITDA analysis, ideally begins 2 to 5 years before the target sale date. Owners who start that preparation early usually have far more leverage than those who begin the process under time pressure.
What is rollover equity in a DSO deal, and how should I evaluate it?
Rollover equity is the portion of a DSO deal paid not as cash at closing but as an ownership stake in the acquiring platform. In a typical DSO transaction, as much as 40% of the total deal value may be structured as rollover equity rather than cash. That equity can be held at the joint-venture, or JV, level, tied to your specific practice and often with ongoing distributions, or at the holding-company level, which offers no distributions but potentially higher upside if the platform is later recapitalized or sold at a higher multiple. Rollover equity is illiquid and converts to cash only at a future recapitalization or sale event, typically 3 to 7 years after your transaction, and that event is not guaranteed. Evaluating rollover equity requires underwriting the DSO itself, which means assessing its profitability, revenue growth, management team, and the financial strength of its private equity sponsor, similar to how you would evaluate any investment. A good sell-side advisor can help you model the realistic range of outcomes for the equity component across multiple scenarios, so you can compare the economic value of competing offers rather than relying only on headline numbers.
What is the most common mistake dental practice owners make in succession planning?
As noted in Phase 5, treating succession planning as a one-time event rather than an ongoing process is the most common mistake, and starting too late often makes it worse. Many owners begin thinking about a transition only when a triggering event occurs, such as an unsolicited DSO offer, a health scare, a partnership dispute, or burnout. At that point, the planning window has already compressed, the practice may not be prepared for sale, and the owner is negotiating from a reactive position rather than a proactive one. A related mistake involves accepting a single offer without creating competitive tension. An owner who negotiates directly with one buyer, whether a DSO or an individual dentist, has no way to know whether that offer reflects the real market and limited leverage to improve it. A structured, multi-buyer process tends to produce better outcomes than any single-buyer negotiation, even when the initial offer appears attractive.
Should I sell my dental practice to a private buyer or a DSO?
The right answer depends on your practice’s size and profitability, your personal goals, and your financial priorities. Smaller premier practices, generally in the $1 million to $1.5 million revenue range, often fit a doctor-to-doctor sale, which delivers 100% cash at closing and a short transition period. Larger practices, particularly those above $1.5 million in revenue with strong EBITDA margins and associate coverage, may attract meaningful DSO interest and a materially higher headline valuation, although that valuation usually comes with rollover equity, earnouts, and a multi-year post-close work commitment. Owners in the $1.5 million to $3 million revenue range are often positioned for either path, and the right choice usually depends on a side-by-side financial model that compares real after-tax proceeds across both options over multiple time horizons. Because McLerran & Associates works both pathways in roughly equal measure, the firm can produce that comparison without a bias toward either path and give owners the information they need to choose with more confidence.
